TREATMENT OF HCV INFECTION BY A COMBINATION OF SOFOSBUVIR AND DACLATASVIR

The purpose of the review is to evaluate the efficacy and safety of using pangenotypic combination «of Sofosbuvir/Daclatasvir» — the direct action antiviral drugs in the treatment of chronic HCV infection at different stages of liver damage.Main provisions: Sofosbuvir is the antisense nucleotide, in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Y. O. SHULPEKOVA, N. V. SHULPEKOVA, M. C. SEMENISTAYA, A. A. USANOVA, C. S. PAVLOV
Format: Artigo
Jezik:Russo
Izdano: Remedium Group LLC 2017-05-01
Serija:Медицинский совет
Teme:
direct action antiviral drug
sofosbuvir/daclatasvir
hepatitis
fibrosis
cirrhosis
liver transplantation
indications for treatment of chronic hcv infection
Online pristup:https://www.med-sovet.pro/jour/article/view/1849
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items